Hologen and Sysmex establish Saibogen, a joint venture using AI to turn routine blood test data into clinical intelligence

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />LONDON and KOBE, Japan, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Hologen (HQ: London, UK; CEO: Roland Tegeder), a frontier AI company, and Sysmex Corporation (HQ: Kobe, Japan; President: Iwane Matsui), a global leader in hematology, today announced...